Differences in long-term outcome after femoral, subclavian and
aortic approach to transcatheter aortic valve implantation
(TAVI)

J 2014

Differences in long-term outcome after femoral, subclavian and aortic approach to transcatheter aortic valve implantation (TAVI)

BRANNY, Marian; Piotr BRANNY; Jaroslav JANUSKA; Miroslav HUDEC; Krystyna KLUZOVA et al.

Základní údaje

Originální název

Differences in long-term outcome after femoral, subclavian and aortic approach to transcatheter aortic valve implantation (TAVI)

Autoři

BRANNY, Marian; Piotr BRANNY; Jaroslav JANUSKA; Miroslav HUDEC; Krystyna KLUZOVA; Pavla KUFOVA; Libor SKNOURIL; Jiří JARKOVSKÝ ; Milan BLAHA a Petr KALA

Vydání

Experimental & clinical card, Toronto, Cardiology Academic Press, 2014, 1205-6626

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 0.758 v roce 2013

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/14:00078124

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Aortic valve implantation; Transaortic approach; Long-term mortality; TAVI; Aortic stenosis

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 9. 1. 2015 11:07, Soňa Böhmová

Anotace

V originále

Introduction: Transcatheter aortic valve implantation (TAVI) represents an effective treatment of high-risk patients with severe aortic stenosis. There is no evidence of the long-term outcome of alternative approaches to TAVI. Aim: To asses the clinical outcome after subclavian and aortic TAVI compared to standard femoral approach. Methods: Prospective single-centre study comprise 228 consecutive TAVI patients (average age 79 years, logistic EuroSCORE 17.2, 53.5% females) divided in 1)Femoral, 2)Aortic and 3)Subclavian groups. More peripheral artery disease was found in both Aortic and Subclavian groups. The self-expandable CoreValve (Medtronic Inc., Minneapolis, MN USA) stented prosthesis was exclusively implanted. Results: In 99.6% the valve was successfully deployed. At 30 days the mortality and bleeding occurred in 2.6% and 3.5%, respectively, irrespective of the approach. The long-term major adverse cardiovascular events (MACE)and mortality rate were higher in patients after transaortic TAVI (mortality - 31.3% at 1 year; 65.6% at 2 years in aortic, 14,7%; 24.1% in femoral and 13.1%; 24.7% in subclavian groups, respectively; p=0.043, MACE; p=0.031). Conclusion: Compared to the femoral and subclavian approaches, patients after transaortic TAVI have significantly higher MACE and mortality rate up to 2 years.

Citovat

BRANNY, Marian; Piotr BRANNY; Jaroslav JANUSKA; Miroslav HUDEC; Krystyna KLUZOVA; Pavla KUFOVA; Libor SKNOURIL; Jiří JARKOVSKÝ; Milan BLAHA a Petr KALA. Differences in long-term outcome after femoral, subclavian and aortic approach to transcatheter aortic valve implantation (TAVI). Experimental & clinical card. Toronto: Cardiology Academic Press, 2014, roč. 20, č. 8, s. 2658-2671. ISSN 1205-6626.

@article{1215450,
   author = {Branny, Marian and Branny, Piotr and Januska, Jaroslav and Hudec, Miroslav and Kluzova, Krystyna and Kufova, Pavla and Sknouril, Libor and Jarkovský, Jiří and Blaha, Milan and Kala, Petr},
   article_location = {Toronto},
   article_number = {8},
   keywords = {Aortic valve implantation; Transaortic approach; Long-term mortality; TAVI; Aortic stenosis},
   language = {eng},
   issn = {1205-6626},
   journal = {Experimental & clinical card},
   title = {Differences in long-term outcome after femoral, subclavian and aortic approach to transcatheter aortic valve implantation (TAVI)},
   volume = {20},
   year = {2014}
}

TY  - JOUR
ID  - 1215450
AU  - Branny, Marian - Branny, Piotr - Januska, Jaroslav - Hudec, Miroslav - Kluzova, Krystyna - Kufova, Pavla - Sknouril, Libor - Jarkovský, Jiří - Blaha, Milan - Kala, Petr
PY  - 2014
TI  - Differences in long-term outcome after femoral, subclavian and aortic approach to transcatheter aortic valve implantation (TAVI)
JF  - Experimental & clinical card
VL  - 20
IS  - 8
SP  - 2658-2671
EP  - 2658-2671
PB  - Cardiology Academic Press
SN  - 12056626
KW  - Aortic valve implantation
KW  - Transaortic approach
KW  - Long-term mortality
KW  - TAVI
KW  - Aortic stenosis
N2  - Introduction: Transcatheter aortic valve implantation (TAVI) represents an effective treatment of high-risk patients with severe aortic stenosis. There is no evidence of the long-term outcome of alternative approaches to TAVI. Aim: To asses the clinical outcome after subclavian and aortic TAVI compared to standard femoral approach. Methods: Prospective single-centre study comprise 228 consecutive TAVI patients (average age 79 years, logistic EuroSCORE 17.2, 53.5% females) divided in 1)Femoral, 2)Aortic and 3)Subclavian groups. More peripheral artery disease was found in both Aortic and Subclavian groups. The self-expandable CoreValve (Medtronic Inc., Minneapolis, MN USA) stented prosthesis was exclusively implanted. Results: In 99.6% the valve was successfully deployed. At 30 days the mortality and bleeding occurred in 2.6% and 3.5%, respectively, irrespective of the approach. The long-term major adverse cardiovascular events (MACE)and mortality rate were higher in patients after transaortic TAVI (mortality - 31.3% at 1 year; 65.6% at 2 years in aortic, 14,7%; 24.1% in femoral and 13.1%; 24.7% in subclavian groups, respectively; p=0.043, MACE; p=0.031). Conclusion: Compared to the femoral and subclavian approaches, patients after transaortic TAVI have significantly higher MACE and mortality rate up to 2 years.
ER  -

BRANNY, Marian; Piotr BRANNY; Jaroslav JANUSKA; Miroslav HUDEC; Krystyna KLUZOVA; Pavla KUFOVA; Libor SKNOURIL; Jiří JARKOVSKÝ; Milan BLAHA a Petr KALA. Differences in long-term outcome after femoral, subclavian and aortic approach to transcatheter aortic valve implantation (TAVI). \textit{Experimental \&{} clinical card}. Toronto: Cardiology Academic Press, 2014, roč.~20, č.~8, s.~2658-2671. ISSN~1205-6626.

Přehled o publikaci